Company: NAVN
Filing Date: 2025-06-20
Form Type: DRS
Source: 0001628279-25-000383
Chunk: 119

Company: Navan, Inc.
Filing Date: 2025-06-20
Form: DRS
Chunk 119
---
 per share; no shares authorized, issued, and outstanding, actual;         shares authorized,         shares issued and outstanding, pro forma;          shares authorized,         shares issued and outstanding, pro forma as adjusted |     |                                                | — |     |           |     |              |
| Additional paid-in capital                                                                                                                                                                                                                                                          |     |                                                |   |     |           |     |              |
| Accumulated other comprehensive loss                                                                                                                                                                                                                                                |     |                                                |   |     |           |     |              |
| Accumulated deficit                                                                                                                                                                                                                                                                 |     |                                                |   |     |           |     |              |
| Total stockholders’ (deficit) equity                                                                                                                                                                                                                                                |     |                                                | — |     |           |     |              |
| Total capitalization                                                                                                                                                                                                                                                                |     |                                              $ | — |     |           |     |              |

_______________

(1) Each $1.00 increase (decrease) in the assumed initial public offering price of $ per share, which is the midpoint of the offering price range set forth on the cover page of this prospectus, would increase (decrease) our pro forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders’ (deficit) equity, and total capitalization by $ million, assuming that the number of shares offered by us, as set forth on the

<div align='center'>80</div>

cover page of this prospectus, remains the same and after deducting the underwriting discounts and commissions. Similarly, each increase (decrease) of 1.0 million shares in the number of shares of our Class A common stock offered by us would increase (decrease) the amount of our pro forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders’ (deficit) equity, and total capitalization by $ million, assuming that the assumed initial public offering price remains the same, and after deducting the underwriting discounts and commissions. If the underwriters’ option to purchase additional shares is exercised in full, the pro forma as adjusted amount of each of cash and cash equivalents, additional paid-in capital, total stockholders’ (deficit) equity, and total capitalization would increase by $ million, and after deducting underwriting discounts and commissions, and we would have shares of our Class A common stock and shares of our Class B common stock issued and outstanding.

(2) ABL Facility consists of $100 million of principal amount under a revolving credit facility, net of unam